258 related articles for article (PubMed ID: 11930185)
1. Assessment of myocardial viability by positron emission tomography.
Segall G
Nucl Med Commun; 2002 Apr; 23(4):323-30. PubMed ID: 11930185
[TBL] [Abstract][Full Text] [Related]
2. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2005; 5(16):1-167. PubMed ID: 23074467
[TBL] [Abstract][Full Text] [Related]
3. [Assessment of myocardial viability by FDG-PET].
Momose M; Kondo C
Rinsho Byori; 2007 Jul; 55(7):639-47. PubMed ID: 17718060
[TBL] [Abstract][Full Text] [Related]
4. 18-Fluorodeoxyglucose imaging with positron emission tomography and single photon emission computed tomography: cardiac applications.
Bax JJ; Patton JA; Poldermans D; Elhendy A; Sandler MP
Semin Nucl Med; 2000 Oct; 30(4):281-98. PubMed ID: 11105929
[TBL] [Abstract][Full Text] [Related]
5. F-18 fluoro deoxyglucose SPECT for assessment of myocardial viability.
Fitzgerald J; Parker JA; Danias PG
J Nucl Cardiol; 2000; 7(4):382-7. PubMed ID: 10958281
[TBL] [Abstract][Full Text] [Related]
6. Clinical importance of viability assessment in chronic ischemic heart failure.
Calhoun WB; Mills RM; Drane WE
Clin Cardiol; 1996 May; 19(5):367-9. PubMed ID: 8723594
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of hibernating myocardium.
Mari C; Strauss WH
Nucl Med Commun; 2002 Apr; 23(4):311-22. PubMed ID: 11930184
[TBL] [Abstract][Full Text] [Related]
8. Prediction of improvement of ventricular function after revascularization. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography.
Cornel JH; Bax JJ; Fioretti PM; Visser FC; Maat AP; Boersma E; van Lingen A; Elhendy A; Roelandt JR
Eur Heart J; 1997 Jun; 18(6):941-8. PubMed ID: 9183585
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
[TBL] [Abstract][Full Text] [Related]
10. Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
Wu YW; Tadamura E; Yamamuro M; Kanao S; Marui A; Tanabara K; Komeda M; Togashi K
J Nucl Med; 2007 Jul; 48(7):1096-103. PubMed ID: 17607039
[TBL] [Abstract][Full Text] [Related]
11. Low-dose dobutamine electrocardiograph-gated myocardial SPECT for identifying viable myocardium: comparison with dobutamine stress echocardiography and PET.
Yoshinaga K; Morita K; Yamada S; Komuro K; Katoh C; Ito Y; Kuge Y; Kohya T; Kitabatake A; Tamaki N
J Nucl Med; 2001 Jun; 42(6):838-44. PubMed ID: 11390545
[TBL] [Abstract][Full Text] [Related]
12. Electromechanical mapping versus positron emission tomography and single photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy.
Wiggers H; Bøtker HE; Søgaard P; Kaltoft A; Hermansen F; Kim WY; Krusell L; Thuesen L
J Am Coll Cardiol; 2003 Mar; 41(5):843-8. PubMed ID: 12628732
[TBL] [Abstract][Full Text] [Related]
13. [Myocardial tissue vitality: clinical relevance, pathophysiology and identification].
Bax JJ; Cornel JH; Poldermans D; van Eck-Smit BL; van der Wall EE
Ned Tijdschr Geneeskd; 1998 Jan; 142(2):67-71. PubMed ID: 9556996
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the clinical value of combination of 99mTc-MIBI myocardial SPECT and 18F-FDG PET in assessing myocardial viability.
Zhang X; Liu X; Shi R; Wu Q; Gao R; Liu Y; Hu S; Guo S; Xie F; Li Y
Radiat Med; 1999; 17(3):205-10. PubMed ID: 10440109
[TBL] [Abstract][Full Text] [Related]
15. Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
Santana CA; Faber TL; Soler-Peter M; Sanyal R; Esteves FP; Ornelas M; Folks RD; Verdes L; Santana LF; Candell-Riera J; Garcia EV
Nucl Med Commun; 2008 Nov; 29(11):970-81. PubMed ID: 18836375
[TBL] [Abstract][Full Text] [Related]
16. [Assessing myocardial viability in chronic myocardial infarct with 18F-fluoro-D-glucose positron emission tomography and 99mTc-MIBI SPECT].
Schneider CA; Voth E; Theissen P; Wienhard K; Wagner R; Baer FM; Sechtem U; Schicha H
Z Kardiol; 1994 Feb; 83(2):124-31. PubMed ID: 8165842
[TBL] [Abstract][Full Text] [Related]
17. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
Ling LF; Marwick TH; Flores DR; Jaber WA; Brunken RC; Cerqueira MD; Hachamovitch R
Circ Cardiovasc Imaging; 2013 May; 6(3):363-72. PubMed ID: 23595888
[TBL] [Abstract][Full Text] [Related]
18. Role of F-18 FDG positron emission tomography (PET) in the assessment of myocardial viability.
Ghesani M; Depuey EG; Rozanski A
Echocardiography; 2005 Feb; 22(2):165-77. PubMed ID: 15693785
[TBL] [Abstract][Full Text] [Related]
19. Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
Gerber BL; Vanoverschelde JL; Bol A; Michel C; Labar D; Wijns W; Melin JA
Circulation; 1996 Aug; 94(4):651-9. PubMed ID: 8772684
[TBL] [Abstract][Full Text] [Related]
20. Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy.
Isobe S; Ando A; Nanasato M; Nonokawa M; Izawa H; Sobue T; Hirai M; Ito K; Ishigaki T; Murohara T; Yokota M
Nucl Med Commun; 2003 Oct; 24(10):1071-80. PubMed ID: 14508163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
